News Conference News ESOC 2025 Don’t Forget to Floss! Better Oral Hygiene May Help Stave Off Stroke Todd Neale May 23, 2025
News Daily News Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE Yael L. Maxwell February 14, 2025
News Conference News AHA 2023 Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients Caitlin E. Cox November 07, 2023
News Daily News PCSK9 Inhibition Shows Promise for Severe COVID-19 in Pilot Trial Todd Neale January 18, 2023
News Daily News New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT Caitlin E. Cox July 08, 2022
News Daily News Pills for Erectile Dysfunction Linked to Fewer CVD Deaths Caitlin E. Cox March 24, 2021
News Daily News Omega-3 PUFAs Offset Adverse CV Effects of Air Pollution in Small, Chinese Study Michael O'Riordan April 24, 2019
News Conference News AHA 2018 Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis Caitlin E. Cox November 13, 2018
News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Conference News ACC 2018 Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS Michael O'Riordan March 12, 2018
News Conference News AHA 2017 CANTOS: Big Drop in CVD Events Among Canakinumab Responders Michael O'Riordan November 13, 2017
News Daily News Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests Michael O'Riordan October 20, 2017
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017